Sign in

CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company

NRX Pharmaceuticals, Inc.

Sign in to watch
Ticker
NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822844431
Phone
484-254-6134
Business address
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
Former names
Big Rock Partners Acquisition Corp.
  1. 4 Open-market sale 10% owner sold 22,171 shares at an average $1.50 ($33,352)
  2. 4 Open-market buy Director bought 11,750 shares at an average $1.25 ($14,663)
  3. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 16,337 shares at an average $1.11 ($18,215)
  4. 4/A Open-market buy Director bought 500,000 shares at an average $1.03 ($514,905)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy Director bought 500,000 shares at an average $1.03 ($514,905)
  9. 4 Open-market sale 10% owner sold 166,737 shares at an average $1.03 ($171,138)
  10. 4 Open-market sale 10% owner sold 49,200 shares at $1.01 ($49,510)
  11. 10-Q Report Quarterly Report
  12. 8-K Event Material agreement · Results of operations
  13. 8-K Event Material agreement · New debt or obligation · Other events
  14. SC 13D Stake Beneficial Ownership Report
  15. 8-K Event Other events
  16. 10-Q Report Quarterly Report
  17. 10-Q/A Report 10-Q/A
  18. 10-Q/A Report 10-Q/A
  19. 8-K Event Restatement
  20. 4 Open-market sale 10% owner sold 784,063 shares at $1.01 ($791,433)

Page 10 of 24 · 479 filings